Despite the success of contemporary melanoma therapies for advanced disease, early detection and excision of curable melanomas remain an important strategy for preventing deaths. Improvements in early detection over the past several decades have been accomplished through raising public awareness, educating health care professionals, and adopting novel technologies. In this issue of JAMA Dermatology, Watts et al1 report on the survival associated with melanoma detected by routine skin check vs other scenarios to indirectly measure the efficacy of melanoma screening.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Halpern AC, Marchetti MA. Melanoma Screening—Time for a Reset? JAMA Dermatol. Published online November 03, 2021. doi:10.1001/jamadermatol.2021.3883
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.